Company Listing
MEDIAN Technologies

MEDIAN is developing next generation medical imaging technology dedicated to oncology clinical trials, cancer screening, and clinical practice.The technology enables pharmaceutical customers and clinicians to accurately measure 3D changes in tumour morphology, including density gradients, to optimise the diagnosis of cancer patients and the assessment of their response to therapy. MEDIAN is a VIPE (Venture Investment in Public Equity) and is listed on Euronext.

BACK
Location
Sophia Antipolis, France
CEO
Fredrik Brag
Abingworth Partner
Tim Haines
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

MEDIAN is developing next generation medical imaging technology dedicated to oncology clinical trials, cancer screening, and clinical practice.The technology enables pharmaceutical customers and clinicians to accurately measure 3D changes in tumour morphology, including density gradients, to optimise the diagnosis of cancer patients and the assessment of their response to therapy. MEDIAN is a VIPE (Venture Investment in Public Equity) and is listed on Euronext.

Location
Sophia Antipolis, France
CEO
Fredrik Brag
Abingworth Partner
Tim Haines
Website Address
BACK
 
Copyright Abingworth 2017